BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 12067996)

  • 1. Omomyc, a potential Myc dominant negative, enhances Myc-induced apoptosis.
    Soucek L; Jucker R; Panacchia L; Ricordy R; Tatò F; Nasi S
    Cancer Res; 2002 Jun; 62(12):3507-10. PubMed ID: 12067996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation.
    Lüscher B; Larsson LG
    Oncogene; 1999 May; 18(19):2955-66. PubMed ID: 10378692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of Max: role of basic, helix-loop-helix/leucine zipper domains in DNA binding, dimerization and regulation of Myc-mediated transcriptional activation.
    Reddy CD; Dasgupta P; Saikumar P; Dudek H; Rauscher FJ; Reddy EP
    Oncogene; 1992 Oct; 7(10):2085-92. PubMed ID: 1408152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene-regulatory properties of Myc helix-loop-helix/leucine zipper mutants: Max-dependent DNA binding and transcriptional activation in yeast correlates with transforming capacity.
    Crouch DH; Fisher F; Clark W; Jayaraman PS; Goding CR; Gillespie DA
    Oncogene; 1993 Jul; 8(7):1849-55. PubMed ID: 8510929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omomyc expression in skin prevents Myc-induced papillomatosis.
    Soucek L; Nasi S; Evan GI
    Cell Death Differ; 2004 Sep; 11(9):1038-45. PubMed ID: 15143346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and properties of a Myc derivative that efficiently homodimerizes.
    Soucek L; Helmer-Citterich M; Sacco A; Jucker R; Cesareni G; Nasi S
    Oncogene; 1998 Nov; 17(19):2463-72. PubMed ID: 9824157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
    Gupta K; Anand G; Yin X; Grove L; Prochownik EV
    Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low molecular weight inhibitors of Myc-Max interaction and function.
    Yin X; Giap C; Lazo JS; Prochownik EV
    Oncogene; 2003 Sep; 22(40):6151-9. PubMed ID: 13679853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of sequences responsible for the differential regulation of Myc function by delta Max and Max.
    Västrik I; Mäkelä TP; Koskinen PJ; Alitalo K
    Oncogene; 1995 Aug; 11(3):553-60. PubMed ID: 7630640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA binding of Myc/Max/Mad network complexes to oligonucleotides containing two E box elements: c-Myc/Max heterodimers do not bind DNA cooperatively.
    Vervoorts J; Lüscher B
    Biol Chem; 1999 Sep; 380(9):1121-6. PubMed ID: 10543451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of the widely expressed dMax splice variant of Max on E-box vs initiator element-mediated regulation by c-Myc.
    FitzGerald MJ; Arsura M; Bellas RE; Yang W; Wu M; Chin L; Mann KK; DePinho RA; Sonenshein GE
    Oncogene; 1999 Apr; 18(15):2489-98. PubMed ID: 10229200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Myc does not require max for transcriptional activity in PC-12 cells.
    Ribon V; Leff T; Saltiel AR
    Mol Cell Neurosci; 1994 Jun; 5(3):277-82. PubMed ID: 8087425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure, function, and dynamics of the dimerization and DNA-binding domain of oncogenic transcription factor v-Myc.
    Fieber W; Schneider ML; Matt T; Kräutler B; Konrat R; Bister K
    J Mol Biol; 2001 Apr; 307(5):1395-410. PubMed ID: 11292350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both the helix-loop-helix and the leucine zipper motifs of c-Myc contribute to its dimerization specificity with Max.
    Davis LJ; Halazonetis TD
    Oncogene; 1993 Jan; 8(1):125-32. PubMed ID: 8423990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functions of myc:max in the control of cell proliferation and tumorigenesis.
    Hurlin PJ; Dezfouli S
    Int Rev Cytol; 2004; 238():183-226. PubMed ID: 15364199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Myc-interacting proteins: a second Myc network emerges.
    Sakamuro D; Prendergast GC
    Oncogene; 1999 May; 18(19):2942-54. PubMed ID: 10378691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the DNA-binding activities of Myc/Max/Mad network complexes during induced differentiation of U-937 monoblasts and F9 teratocarcinoma cells.
    Larsson LG; Bahram F; Burkhardt H; Lüscher B
    Oncogene; 1997 Aug; 15(6):737-48. PubMed ID: 9264414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NMR solution structure of a mutant of the Max b/HLH/LZ free of DNA: insights into the specific and reversible DNA binding mechanism of dimeric transcription factors.
    Sauvé S; Tremblay L; Lavigne P
    J Mol Biol; 2004 Sep; 342(3):813-32. PubMed ID: 15342239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc.
    Yang W; Shen J; Wu M; Arsura M; FitzGerald M; Suldan Z; Kim DW; Hofmann CS; Pianetti S; Romieu-Mourez R; Freedman LP; Sonenshein GE
    Oncogene; 2001 Mar; 20(14):1688-702. PubMed ID: 11313917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of transcriptional repression by max homodimers.
    Yin X; Grove L; Prochownik EV
    Oncogene; 1998 May; 16(20):2629-37. PubMed ID: 9632139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.